Sanofi Pasteur


LYON, France, September 20, 2011 - - Vaccine strain used in the production of oral polio vaccines against type 3 poliovirus - Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today it is donating to the World Health Organization (WHO) a vaccine strain used for polio eradication.

LYON, France, July 7, 2011 - - Newcomer's Biopharmaceutical Experience to Further Develop European Joint-Venture - MSD, known as Merck in the United States and Canada (NYSE: MRK), and Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), the two partner companies in Sanofi Pasteur MSD, announce today the appointment of Dr.

LYON, France and SWIFTWATER, Pennsylvania, February 23, 2011 - Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), today will participate in the first international bell-ringing event by a company listed on NYSE Euronext.

LYON, France, February 21, 2011 - Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that it is partnering with the International Vaccine Institute (IVI) to support the recently launched Dengue Vaccine Initiative (DVI).

LYON, France, November 4, 2010 - Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that its dengue vaccine is in final stage of clinical development.
Older News
S M T W T F S
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
Copyright© 2011 The Gaea Times